期刊文献+

肝细胞癌螺旋CT增强表现与癌细胞雌激素受体表达的相关性初探 被引量:7

Hepatocellular carcinoma: initial study of spiral CT findings with expression of estrogen receptor correlation
原文传递
导出
摘要 目的 探讨螺旋CT增强扫描反映肝细胞癌雌激素受体 (ER)表达的可能性。方法 经病理证实的肝细胞癌患者 43例 ,其中动态扫描 2 6例 ,评价时间 -密度曲线走势并计算癌灶强化峰值(PV)和强化比值 (CER) ;动、门脉双期扫描 17例 ;观察癌灶强化表现特征、包膜、子灶和门脉癌栓。组织切片经ER免疫组化染色。结果 癌细胞ER阳性 2 1例 ,阳性率 48.8% ,ER阳性组肿瘤平均横径5 .1cm ,ER阴性组为 7.0cm。ER阳性组癌灶PV、CER小于ER阴性组。有明确包膜组ER阳性率高 ,伴发子灶、门脉癌栓组ER阳性率低。 Objective To investigate the enhancement imaging features of hepatocellular carcinoma (HCC) and relevant parameters revealed by spiral CT scanning, and its correlation with the expression of estrogen receptor (ER). Methods The study included 43 histopathologically proven HCC patients. Among them, 26 cases underwent single level dynamic spiral CT scanning and the portal venous phase scanning of whole liver, and the rest 17 cases underwent dual phase scanning of whole liver. We evaluated the time density curve (T DC) and calculated the peak value (PV), and contrast enhancement ratio (CER). The enhancement imaging features, pseudocapsules, intrahepatic daughter foci, and tumor emboli in portal veins were observed. Slides were stained with the standard immunoperoxidase method using the estrogen receptor (ER) monoclonal antibody to determine the ER expression. Results Twenty one cases were ER positive (48.8%). The mean diameter of the ER positive lesions were 5.1 cm, while the ER negative cases were 7.0 cm. The PV and CER of HCC lesions in the positive cases were lower than that in the negative cases. ER positive percentage was higher in cases with pseudocapsules than in that without. ER positive percentage was very low in cases of HCC lesions with intrahepatic daughter foci and tumor emboli in portal veins. Conclusion The enhancement imaging features of HCC revealed by spiral CT could indicate the expression of ER to a certain degree.
机构地区 华西医科大学
出处 《中华放射学杂志》 CAS CSCD 北大核心 2000年第10期675-679,共5页 Chinese Journal of Radiology
基金 1998年四川省第 2批重点科技项目!(川科委计〔1998〕13号第 16项 )
关键词 肝细胞癌 雌激素受体 螺旋CT增强 相关性 Tomography X ray computed Carcinoma hepatocellular Estrogen recepto€
  • 相关文献

参考文献2

二级参考文献2

  • 1刘东屏,1988年
  • 2顾公望,国外医学肿瘤学分册,1987年,6期,324页

共引文献6

同被引文献43

  • 1吴阶平.泌尿外科学[M].济南:山东科学技术出版社,1995.653.
  • 2黄兴耀.关于肝癌的分型、分期标准的商榷[J].中华肝脏病杂志,1999,7(3):168-168.
  • 3Roy AK, Lavrovsky Y, Song CS, et al. Regulation of androgen action. Vit Horm, 1999,55:309.
  • 4Brooke GN, Parker MG, Bevan CL. Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression. Oneogene ,2007,26 : 1757.
  • 5Kase AO, Chinnakannu K, Chen D, et al. Androgen receptor and E2F-1 targeted thymoquinonc therapy for hormone-refractory prostate cancer, 2007,67 : 7782.
  • 6Dehm SM,Tindall DJ. Androgen receptor structural and functional elements: role and regulation in prostate cancer. Mol Endocrinol, 2007,21:2855.
  • 7Zora C, Helmut K, Georg B, et al. Androgen receptor mutation in carcinoma of the prostate: significance for endocrine therapy. Am J of Pharm,2001,1:241.
  • 8Chiu FL,Lin JK. Downregulation of androgen receptor expression by luteolin causes inbibilion of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts. Prostate,2008, 68:61.
  • 9Taplin ME, Bubley GT,Shuster TD. Mutation of the androgen receptor in metastatic androgen-independent prostate cancer. New Engl J Med, 1995,332 : 1393.
  • 10Elo JP,Kvist L,Leinonen K. Mutated human androgen receptor gene detected in a prostate cancer patient is also activated by estradiol. J Clin Endocri Metab, 1995,80:3494.

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部